Antiviral Agents [clinicaltrials_resource:a55c193ce38c04b78843d27f00b66c8a]
condition [clinicaltrials_vocabulary:condition]
A Phase I Clinical Trial To Evaluate the Toxicity, Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected Subjects [clinicaltrials:NCT00000713]A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC [clinicaltrials:NCT00000735]Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine [clinicaltrials:NCT00000838]A Six-Month Safety and Antiviral Study in HIV-1 Seropositive, AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cells/mm3 to Evaluate MK-639 Alone Versus Zidovudine (AZT) and 3TC Versus the Combination of MK-639 With AZT/3TC [clinicaltrials:NCT00002155]Antiviral Therapy in Treating Patients With Slowly Progressing HIV-Related Kaposi's Sarcoma [clinicaltrials:NCT00003419]Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer [clinicaltrials:NCT00003435]Neurocognitive Functioning in Patients With Hepatitis C Pre- and Post-Treatment With Antiviral Medication [clinicaltrials:NCT00188201]Assessment of the Antiviral Effect of Atorvastatin on Hepatitis C Virus [clinicaltrials:NCT00403533]Bioavailability Study of a New Pediatric Formulation of Zidovudine/Lamivudine in Adult Volunteers [clinicaltrials:NCT00470041]A Study of the PK, Safety and Antiviral Activity of A-831 in HCV Carriers [clinicaltrials:NCT00522808]FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of Response to Antiviral Therapy [clinicaltrials:NCT00606528]clinicaltrials:NCT00647946clinicaltrials:NCT00671671Intravenous Silibinin in Combination With Peg-interferon and Ribavirin in Nonresponders [clinicaltrials:NCT00684268]clinicaltrials:NCT00768157clinicaltrials:NCT00784784Influence of Antiviral Treatment to the Long-Term Prognosis of Patients With Chronic HBV Infection [clinicaltrials:NCT00810524]clinicaltrials:NCT00838162Nutritional Support During Antiviral Therapy for Hepatitis C [clinicaltrials:NCT00841243]Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1) : Multi-centre, Prospective, Randomized Controlled Study [clinicaltrials:NCT00935194]Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C [clinicaltrials:NCT00948220]clinicaltrials:NCT00996216clinicaltrials:NCT01027065Safety and Efficacy Study for a New Antiviral Drug to Treat Genital Herpes Type 2 [clinicaltrials:NCT01047540]clinicaltrials:NCT01077908The Impact of Vitamin on the Clinical Course in Cases Infected by Novel H1N1 Influenza Virus A [clinicaltrials:NCT01127282]Influenza Antiviral DAS181-F03 [clinicaltrials:NCT01173224]Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant [clinicaltrials:NCT01199562]clinicaltrials:NCT01248715Antiviral Treatment of Chronic Lymphocytic Leukemia [clinicaltrials:NCT01255644]clinicaltrials:NCT01309932The Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus-drug Test [clinicaltrials:NCT01312012]A First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2485852 in Chronically Infected Hepatitis C Subjects [clinicaltrials:NCT01332552]Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection [clinicaltrials:NCT01371578]clinicaltrials:NCT01610765The Effects of the Direct Acting Antiviral Agent Boceprevir on the Pharmacokinetics of Maraviroc in Healthy Volunteers [clinicaltrials:NCT01627717]AV2 Antiviral Spray Versus Placebo in Human Papillomavirus Cervix Infections [clinicaltrials:NCT01654822]clinicaltrials:NCT01655212clinicaltrials:NCT01718587clinicaltrials:NCT01795911
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Antiviral Agents [clinicaltrials_resource:a55c193ce38c04b78843d27f00b66c8a]
Bio2RDF identifier
a55c193ce38c04b78843d27f00b66c8a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a55c193ce38c04b78843d27f00b66c8a
identifier
clinicaltrials_resource:a55c193ce38c04b78843d27f00b66c8a
title
Antiviral Agents
@en
type
label
Antiviral Agents [clinicaltrials_resource:a55c193ce38c04b78843d27f00b66c8a]
@en